Isolated Chromosome 6q27 Terminal Deletion Syndrome

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2020 Jun 17

PMID 32542158

Citations 3

Authors

Sabita Bhatta

Marsha Medows

Yogesh Acharya

Affiliations

Soon will be listed here.

Abstract

Any change in either the short (p) or long (q) arm of chromosome six can result in a variety of disorders. A two-year-old female child came to us with a history of sudden onset generalized tonic-clonic seizure. She had a syndromic face with frontal bossing and palpable thinning of the right lower lip and an apparent facial asymmetry while crying due to the hypoplasia of the right depressor angularis oris. Her joints were hypermobile and hypotonic. Chromosomal karyotyping exhibited a normal female karyotype, but pathogenic microarray genetic evaluation showed a loss of approximately 783 kb of the 6q27 terminus. She was diagnosed with chromosome 6q27 terminal deletion and managed with anti-seizure medications. Chromosome 6q27 terminal deletion can present with an array of structural and developmental anomalies. It is, therefore, necessary to understand the typical phenotypic and distinctive clinical features of congenital chromosome 6q27 terminal deletion syndrome for early diagnosis and intervention.

Citing Articles

Terminal 6q27 Microdeletion Syndrome: A Case Report.

Ferreira Vieira M, Carvalho D, Valentim F, Branco D, Marinho H Cureus. 2022; 14(11):e31037.

PMID: 36475138 PMC: 9720043. DOI: 10.7759/cureus.31037.

Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma.

Aksoy Yasar F, Shingu T, Zamler D, Zaman M, Chien D, Zhang Q Front Cell Dev Biol. 2022; 10:931387.

PMID: 36051438 PMC: 9424994. DOI: 10.3389/fcell.2022.931387.

Implication of Genetic Testing and Pregnancy Outcome in a Woman with Unbalanced Translocation t(1;6).

Jurcenko M, Auzenbaha M, Micule I, Grinfelde I, Dzalbs A, Malniece I Am J Case Rep. 2022; 23:e935370.

PMID: 35192596 PMC: 8884151. DOI: 10.12659/AJCR.935370.

References

Rooms L, Reyniers E, Scheers S, van Luijk R, Wauters J, Van Aerschot L . TBP as a candidate gene for mental retardation in patients with subtelomeric 6q deletions. Eur J Hum Genet. 2006; 14(10):1090-6. DOI: 10.1038/sj.ejhg.5201674. View

Sherr E, Owen R, Albertson D, Pinkel D, Cotter P, Slavotinek A . Genomic microarray analysis identifies candidate loci in patients with corpus callosum anomalies. Neurology. 2005; 65(9):1496-8. DOI: 10.1212/01.wnl.0000183066.09239.b6. View

Striano P, Malacarne M, Cavani S, Pierluigi M, Rinaldi R, Cavaliere M . Clinical phenotype and molecular characterization of 6q terminal deletion syndrome: Five new cases. Am J Med Genet A. 2006; 140(18):1944-9. DOI: 10.1002/ajmg.a.31435. View

Kraus J, Lederer G, Keri C, Seidel H, Rost I, Wirtz A . A familial unbalanced subtelomeric translocation resulting in monosomy 6q27-->qter. J Med Genet. 2003; 40(4):e48. PMC: 1735417. DOI: 10.1136/jmg.40.4.e48. View

Jalal S, Harwood A, Sekhon G, Lorentz C, Ketterling R, Babovic-Vuksanovic D . Utility of subtelomeric fluorescent DNA probes for detection of chromosome anomalies in 425 patients. Genet Med. 2003; 5(1):28-34. DOI: 10.1097/00125817-200301000-00005. View

Saldarriaga W, Tassone F, Gonzalez-Teshima L, Forero-Forero J, Ayala-Zapata S, Hagerman R . Fragile X syndrome. Colomb Med (Cali). 2015; 45(4):190-8. PMC: 4350386. View

Eash D, Waggoner D, Chung J, Stevenson D, Martin C . Calibration of 6q subtelomere deletions to define genotype/phenotype correlations. Clin Genet. 2005; 67(5):396-403. DOI: 10.1111/j.1399-0004.2005.00424.x. View

Gerber J, Neuhann T, Tyshchenko N, Smitka M, Hackmann K . Expanding the clinical and neuroradiological phenotype of 6q27 microdeletion: olfactory bulb aplasia and anosmia. Am J Med Genet A. 2011; 155A(8):1981-6. DOI: 10.1002/ajmg.a.34079. View

Martelli Jr H, Miranda R, Fernandes C, Bonan P, Paranaiba L, Graner E . Goldenhar syndrome: clinical features with orofacial emphasis. J Appl Oral Sci. 2011; 18(6):646-9. PMC: 3881767. DOI: 10.1590/s1678-77572010000600019. View

10.

ODriscoll M, Black G, Clayton-Smith J, Sherr E, Dobyns W . Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A. 2010; 152A(9):2145-59. DOI: 10.1002/ajmg.a.33558. View

11.

Bertini V, De Vito G, Costa R, Simi P, Valetto A . Isolated 6q terminal deletions: an emerging new syndrome. Am J Med Genet A. 2005; 140(1):74-81. DOI: 10.1002/ajmg.a.31020. View

12.

Elia M, Striano P, Fichera M, Gaggero R, Castiglia L, Galesi O . 6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases. Epilepsia. 2006; 47(5):830-8. DOI: 10.1111/j.1528-1167.2006.00522.x. View

13.

Peddibhotla S, Nagamani S, Erez A, Hunter J, Lloyd Holder Jr J, Carlin M . Delineation of candidate genes responsible for structural brain abnormalities in patients with terminal deletions of chromosome 6q27. Eur J Hum Genet. 2014; 23(1):54-60. PMC: 4266737. DOI: 10.1038/ejhg.2014.51. View

14.

Picciolini O, Porro M, Cattaneo E, Castelletti S, Masera G, Mosca F . Moebius syndrome: clinical features, diagnosis, management and early intervention. Ital J Pediatr. 2016; 42(1):56. PMC: 4893276. DOI: 10.1186/s13052-016-0256-5. View

15.

Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H . Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet. 2004; 41(4):241-8. PMC: 1735726. DOI: 10.1136/jmg.2003.017731. View

16.

Gilbert F . Chromosome 6. Genet Test. 2003; 6(4):341-58. DOI: 10.1089/10906570260471912. View